Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZW) Payables (2021 - 2025)

Core Scientific (CORZW) has disclosed Payables for 5 consecutive years, with $126.1 million as the latest value for Q4 2025.

  • Quarterly Payables rose 254.68% to $126.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $126.1 million through Dec 2025, up 254.68% year-over-year, with the annual reading at $126.1 million for FY2025, 254.68% up from the prior year.
  • Payables hit $126.1 million in Q4 2025 for Core Scientific, down from $212.2 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $1.0 billion in Q3 2022 to a low of $86179.0 in Q1 2021.
  • Historically, Payables has averaged $144.9 million across 5 years, with a median of $86.8 million in 2021.
  • Biggest five-year swings in Payables: surged 145872.92% in 2022 and later tumbled 87.26% in 2024.
  • Year by year, Payables stood at $87.6 million in 2021, then rose by 2.59% to $89.9 million in 2022, then skyrocketed by 210.52% to $279.1 million in 2023, then crashed by 87.26% to $35.6 million in 2024, then soared by 254.68% to $126.1 million in 2025.
  • Business Quant data shows Payables for CORZW at $126.1 million in Q4 2025, $212.2 million in Q3 2025, and $215.1 million in Q2 2025.